Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

With minimal blood loss and scarring, and faster recovery period, robotic surgeries are becoming game changers in the ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

Artemisia herba-alba shows promise in combating colorectal cancer, offering new hope through its powerful medicinal ...

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

Scientists endow a naturally growing plant with therapeutic properties that can effectively fight colorectal cancer.

That will affect your treatment options and what you can expect -- or as doctors say, your prognosis. Both colon and rectal cancer affect the large intestine, which is the lowest part of the ...